While TB treatment (with rifampin-based regimens) increased MDR-1 expression, there was no significant difference in brain tissues obtained from mice treated with the high- or standard-dose rifampin regimen (Supplemental Figure 15). The gene discussed is ABCB1; the disease is tuberculosis.